Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Polycab India - Q1FY22 First Cut - ICICI Direct

Posted On: 2021-07-22 07:07:24 (Time Zone: UTC)


(CMP: Rs. 1992; MCap: Rs. 28598 crore)

Polycab Q1FY22 performance was impacted due to lockdown in the month of May'21 and delay in passing on of higher input cost.

Q1FY22 Earnings Summary

Polycab's consolidated revenue increased by ~92% YoY at ~Rs. 1880 crore largely on a favourable base of Q1FY21. However, sales recovery was at 96% if compared to pre covid-19 period of Q1FY20. Revenues of wires & cables and FMEG segments increased by ~97% and ~40% YoY to Rs. 1626 crore and Rs. 192 crore respectively

The gross margin declined by ~390 bps YoY and ~200bps QoQ mainly due to delay in passing on of higher input costs. While on YoY basis, EBITDA margin increased by ~150 bps to 7.3% (led by savings in other expenses), the margin is still lower as compared to its historical average range of 12-13%

PBT jumped by 2.5x to Rs. 100 crore, mainly tracking improved sales and margin on a YoY basis. However, PAT came in at Rs. ~75 crore down by ~35% YoY mainly due to one-time tax benefits in the base period

Q1FY22 performance was significantly impacted due to lockdowns owing to the second wave. The demand recovery in core business (i.e. cable and wire business) in the next few quarters would be largely dependent on pick up in government expenditure and the revival of construction activities post easing of the lockdowns. On the margin fronts, improved operating leverage and price hikes in the coming future may trigger meaningful margin recovery for Polycab. We await management commentary on future demand outlook and scope of price hikes to offset inflationary pressure. The detailed report will be released post concall.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

InterGlobe Aviation - Weak quarter, awaiting timelines for fundraise - HDFC Securities

Maintain REDUCE on IndusInd Bank - Reversion to steady state profitability elusive - HDFC Securities

Dr. Reddy's Labs - Weak quarter; outlook intact - HDFC Securities

Maintain BUY on DLF - Robust performance - HDFC Securities

Maintain BUY on Zensar Technologies - Changing the orbit - HDFC Securities

Maintain ADD on TTK Prestige - Steady revenue; miss in margin - HDFC Securities

Maintain ADD on Torrent Pharma - In-line quarter; positive outlook reaffirmed - HDFC Securities

Navin Fluorine International - High opex dents margin - HDFC Securities

Mahindra & Mahindra Financial Services - Portfolio stress peaking out - HDFC Securities

Maintain ADD on Multi Commodity Exchange - Recovery expected - HDFC Securities

Q1FY22 Result Update - Axis Bank - ICICI Direct

Q1FY22 Result Update - Alembic Pharma - ICICI Direct

Q1FY22 Result Update - Larsen & Toubro - ICICI Direct

Quant Pick - Jindal Steel & Power - ICICI Direct

Q1FY22 Company Update - Phillips Carbon Black - ICICI Direct

Q1FY22 Company Update - Zensar Technologies - ICICI Direct

IPO Review - Rolex Rings Ltd - ICICI Direct

Q1FY22 Result Update - Symphony Ltd - ICICI Direct

Coforge Ltd - Q1FY22 First Cut - ICICI Direct

Q2CY21 Company Update - Sanofi India - ICICI Direct

Q1FY22 Result Update - TTK Prestige - ICICI Direct

Greenlam Industries - Q1 FY22 Result Report - YES Securities

Dixon Technologies - Q1 FY22 Result Report - YES Securities

Dr Reddys' Labs - Q1 FY22 Result Report - YES Securities

TTK Prestige - Q1 FY22 Result Report - YES Securities

DLF Ltd - Q1 FY22 Result Report - YES Securities

Torrent Pharma - Q1 FY22 Result Report - YES SEcurities

Mahindra & Mahindra Financial Services - Q1 FY22 Result Report - YES Securities

IndusInd Bank - Q1 FY22 Result Report - YES Securities

Maintain REDUCE on Kotak Mahindra Bank - Strong profitability but growth remains elusive - HDFC Securities

Maintain BUY on Crompton Consumer - ECD continues to be the torchbearer; miss in lighting - HDFC Securities

Maintain BUY on Axis Bank - Back to square one - HDFC Securities

Maintain ADD on United Spirits - In-line volume; mix impacts margin - HDFC Securities

Maintain BUY on Tata Motors - A weak quarter on expected lines; 2H recovery at JLR - HDFC Securities

Maintain ADD on Symphony - Lost summer hampers domestic momentum - HDFC Securities

SBI Life Insurance - Impressive protection share drives margin beat! - HDFC Securities

Maintain BUY on ICICI Bank - Negative surprise on asset quality likely to be transient - HDfC Securities

DLF - Strong show in challenging quarter - ICICI Securities

Stock Tales - Techno Electric & Engineering - ICICI Direct

Quant Pick - Coal India - ICICI Direct

Q1FY22 Result Update - SKF India - ICICI Direct

Q1FY22 Company Update - Saregama India - ICICI Direct

Q1FY22 Result Update - Crompton Greaves Consumer - ICICI Direct

Q1FY22 Result Update - Ambuja Cements - ICICI Direct

Q1FY22 Result Update - SBI Life Insurance - ICICI Direct

Q1FY22 Result Update - Kotak Mahindra Bank - ICICI Direct

Q1FY22 Result Update - Tata Motors - ICICI Direct

Q1FY22 Result Update - Multi Commodity Exchange - ICICI Direct

Company Update - V-Mart - ICICI Direct

Apollo Pipes Ltd Q1FY22 Result First-Cut - YES Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020